Technology-assisted collaborative care program for people with diabetes and/or high blood pressure attending primary health care: a feasibility study
Author
dc.contributor.author
Martínez, Pablo
Author
dc.contributor.author
Guajardo Tobar, Viviana Alejandra
Author
dc.contributor.author
Gómez, Víctor E.
Author
dc.contributor.author
Brandt, Sebastián
Author
dc.contributor.author
Szabo Lagos, Wilsa Margarita
Author
dc.contributor.author
Soto Brandt, Benjamin Gonzalo
Author
dc.contributor.author
Farhang, Maryam
Author
dc.contributor.author
Baeza, Paulina
Author
dc.contributor.author
Campos, Solange
Author
dc.contributor.author
Herrera, Pablo
Author
dc.contributor.author
Rojas Castillo, María Graciela
Admission date
dc.date.accessioned
2022-04-19T15:57:05Z
Available date
dc.date.available
2022-04-19T15:57:05Z
Publication date
dc.date.issued
2021
Cita de ítem
dc.identifier.citation
Int. J. Environ. Res. Public Health 2021, 18, 12000
es_ES
Identifier
dc.identifier.other
10.3390/ijerph182212000
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/184958
Abstract
dc.description.abstract
The comorbidity of depression with physical chronic diseases is usually not considered
in clinical guidelines. This study evaluated the feasibility of a technology-assisted collaborative
care (TCC) program for depression in people with diabetes and/or high blood pressure (DM/HBP)
attending a primary health care (PHC) facility in Santiago, Chile. Twenty people diagnosed with
DM/HBP having a Patient Health Questionnaire-9 score ≥ 15 points were recruited. The TCC
program consisted of a face-to-face, computer-assisted psychosocial intervention (CPI, five biweekly
sessions), telephone monitoring (TM), and a mobile phone application for behavioral activation
(CONEMO). Assessments of depressive symptoms and other health-related outcomes were made.
Thirteen patients completed the CAPI, 12 received TM, and none tried CONEMO. The TCC program
was potentially efficacious in treating depression, with two-thirds of participants achieving response
to depression treatment 12 weeks after baseline. Decreases were observed in depressive symptoms
and healthcare visits and increases in mental health-related quality of life and adherence to treatment.
Patients perceived the CPI as acceptable. The TCC program was partially feasible and potentially
efficacious for managing depression in people with DM/HBP. These data are valuable inputs for a
future randomized clinical trial.
es_ES
Patrocinador
dc.description.sponsorship
National Fund for Scientific and Technological Development, through the grant FONDECYT 1180224
3190275
ANID-Millennium Science Initative/Millennium Institute for Research on Depression and Personality-MIDAP ICS13_005
ANID-Millennium Science Initiative Program NCS17_035
CONICYT/DOCTORADO NACIONAL 2019-21192050
es_ES
Lenguage
dc.language.iso
en
es_ES
Publisher
dc.publisher
MDPI
es_ES
Type of license
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 United States